Department of Molecular Medicine, Helsinki, Finland.
Biol Psychiatry. 2009 Dec 1;66(11):990-6. doi: 10.1016/j.biopsych.2009.05.034. Epub 2009 Sep 27.
While DTNBP1, DISC1, and NRG1 have been extensively studied as candidate genes of schizophrenia, results remain inconclusive. Possible explanations for this are that the genes might be relevant only to certain subtypes of the disease and/or only in certain populations.
We performed unsupervised clustering of individuals from Finnish schizophrenia families, based on extensive clinical and neuropsychological data, including Structured Clinical Interview for DSM-IV (SCID) information. Families with at least one affected member with DSM-IV diagnosis of a schizophrenia spectrum psychosis were included in a register-based ascertainment. Final sample consisted of 904 individuals from 288 families. We then used the cluster phenotypes in a genetic association study of candidate genes.
A robust three-class clustering of individuals emerged: 1) psychotic disorder with mood symptoms (n = 172), 2) core schizophrenia (n = 223), and 3) absence of psychotic disorder (n = 509). One third of the individuals diagnosed with schizophrenia were assigned to cluster 1. These individuals had fewer negative and positive psychotic symptoms and cognitive deficits but more depressive symptoms than individuals in cluster 2. There was a significant association of cluster 2 cases with the DTNBP1 gene, while the DISC1 gene indicated a significant association with schizophrenia spectrum disorders based on the DSM-IV criteria.
In the Finnish population, DTNBP1 gene is associated with a schizophrenia phenotype characterized by prominent negative symptoms, generalized cognitive impairment, and few mood symptoms. Identification of genes and pathways related to schizophrenia necessitates novel definitions of disease phenotypes associated more directly with underlying biology.
虽然 DTNBP1、DISC1 和 NRG1 已被广泛研究为精神分裂症的候选基因,但结果仍不确定。造成这种情况的可能原因是这些基因可能仅与疾病的某些亚型有关,或者仅在某些人群中有关。
我们根据广泛的临床和神经心理学数据(包括 DSM-IV 结构临床访谈(SCID)信息)对芬兰精神分裂症家族的个体进行无监督聚类。包括至少一名受 DSM-IV 诊断为精神分裂症谱系精神病影响成员的家族被纳入基于登记的确定。最终样本由 288 个家庭的 904 名个体组成。然后,我们使用聚类表型进行候选基因的遗传关联研究。
出现了一种稳健的三分类聚类个体:1)伴有情绪症状的精神病性障碍(n = 172),2)核心精神分裂症(n = 223)和 3)无精神病性障碍(n = 509)。三分之一被诊断为精神分裂症的个体被分配到聚类 1。这些个体的阴性和阳性精神病症状以及认知缺陷较少,但抑郁症状比聚类 2 中的个体更多。聚类 2 病例与 DTNBP1 基因存在显著关联,而 DISC1 基因则根据 DSM-IV 标准表明与精神分裂症谱系障碍存在显著关联。
在芬兰人群中,DTNBP1 基因与一种精神分裂症表型相关,其特征为明显的阴性症状、广泛的认知障碍和较少的情绪症状。识别与精神分裂症相关的基因和途径需要与潜在生物学更直接相关的疾病表型的新定义。